Yu Jeong Lee
Overview
Explore the profile of Yu Jeong Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
164
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim M, Yoo H, Lee Y, Jang H, Shim S, Won E, et al.
Parasit Vectors
. 2025 Mar;
18(1):85.
PMID: 40038824
Background: We aimed to investigate whether substances secreted by Clonorchis sinensis excretory/secretory protein (CS-ESP) have an effect on the inflammation of rheumatoid arthritis (RA) and ankylosing spondylitis (AS) and to...
2.
Cho G, Bae H, Lee Y, Yang H, Kang H, Park H, et al.
Biomater Res
. 2025 Feb;
29:0152.
PMID: 39990979
Senescent chondrocytes, which are increased in osteoarthritic (OA) cartilage, promote cartilage defects and the senescent knee microenvironment by inducing senescence to surrounding normal chondrocytes by secreting senescence-associated secretory proteins. Many...
3.
Lee Y, Je N
Br J Clin Pharmacol
. 2025 Jan;
PMID: 39838765
Aims: We aimed to examine the recent trends in the use of acid suppression therapies, including proton pump inhibitors (PPIs), histamine-2 receptor antagonists (H2RAs) and potassium-competitive acid blockers (P-CABs), in...
4.
Lee Y, Kim J, Yu D, Je N, Rhee H
Sci Rep
. 2024 Dec;
14(1):31477.
PMID: 39733180
Proton pump inhibitors (PPIs) are among the most widely used drugs worldwide. However, their influence on the progression of end-stage kidney disease (ESKD) in established chronic kidney disease (CKD) cases...
5.
Lee Y, Li Z, Jang H, Kim M, Saravanakumar K, Shim S, et al.
Front Pharmacol
. 2024 Dec;
15:1456216.
PMID: 39691400
Background: Usenamine A (UA) is a natural compound isolated from the lichen , and its therapeutic effects on rheumatic diseases are not well understood. This study aimed to evaluate the...
6.
Won E, Lee Y, Kim M, Kim T, Shin H, Kim T, et al.
PLoS One
. 2024 Aug;
19(8):e0309446.
PMID: 39196906
Although gastroesophageal reflux has been recognized as one of the risk factors of nontuberculous mycobacterial pulmonary disease (NTM-PD) progression, the effect of reflux on the lower respiratory tract microbiota has...
7.
Choi A, Park K, Kang J, Lee Y, Jang H, Kim M, et al.
J Rheum Dis
. 2024 Jul;
31(3):171-177.
PMID: 38957361
Objective: The purpose of this study is to evaluate the impact of tumor necrosis factor (TNF)-α blocker therapy on the Assessment of SpondyloArthritis international Society Health Index (ASAS-HI) among patients...
8.
Won E, Lee Y, Kim M, Lee H, Jang H, Kim S, et al.
Exp Parasitol
. 2024 Feb;
259:108718.
PMID: 38369180
Helminth infections and their components has been recognized to have a positive impact on the immune system. This study aimed to investigate the potential of Metagonimus yokogawai-derived proteins (MYp) to...
9.
Lee H, Ahn M, Yoo J, Ahn S, Park S, Seo H, et al.
Arthritis Res Ther
. 2024 Jan;
26(1):2.
PMID: 38167497
Background: This study aims to investigate the potential anti-inflammatory effects of exosomes engineered to carry super-repressor IκB (Exo-srIκB), an exosome-based NF-κB inhibitor, in the context of RA. Methods: Peripheral blood...
10.
Lee Y, Kim J, Han Y, Hwang K, Choi B, Oh T, et al.
Drugs R D
. 2023 Jul;
23(3):289-296.
PMID: 37507616
Background And Objective: Tramadol has been reported to cause hyponatremia but the evidence is conflicting. The risk of hyponatremia resulting from combination oral tramadol/acetaminophen (TA) therapy is thus unknown. This...